Duopharma Biotech (Malaysia) Price History
7148 Stock | 1.25 0.01 0.81% |
If you're considering investing in Duopharma Stock, it is important to understand the factors that can impact its price. As of today, the current price of Duopharma Biotech stands at 1.25, as last reported on the 26th of November, with the highest price reaching 1.25 and the lowest price hitting 1.23 during the day. As of now, Duopharma Stock is very risky. Duopharma Biotech Bhd secures Sharpe Ratio (or Efficiency) of 0.0394, which denotes the company had a 0.0394% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Duopharma Biotech Bhd, which you can use to evaluate the volatility of the firm. Please confirm Duopharma Biotech's Mean Deviation of 1.07, coefficient of variation of 4339.52, and Downside Deviation of 1.81 to check if the risk estimate we provide is consistent with the expected return of 0.0662%.
Duopharma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Duopharma |
Sharpe Ratio = 0.0394
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | 7148 | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.68 actual daily | 14 86% of assets are more volatile |
Expected Return
0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Duopharma Biotech is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Duopharma Biotech by adding it to a well-diversified portfolio.
Duopharma Biotech Stock Price History Chart
There are several ways to analyze Duopharma Stock price data. The simplest method is using a basic Duopharma candlestick price chart, which shows Duopharma Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 26, 2024 | 1.4 |
Lowest Price | September 11, 2024 | 1.16 |
Duopharma Biotech November 26, 2024 Stock Price Synopsis
Various analyses of Duopharma Biotech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Duopharma Stock. It can be used to describe the percentage change in the price of Duopharma Biotech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Duopharma Stock.Duopharma Biotech Price Daily Balance Of Power | 0.50 | |
Duopharma Biotech Price Rate Of Daily Change | 1.01 | |
Duopharma Biotech Accumulation Distribution | 3,290 | |
Duopharma Biotech Price Action Indicator | 0.02 |
Duopharma Biotech November 26, 2024 Stock Price Analysis
Duopharma Stock Price History Data
The price series of Duopharma Biotech for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.24 with a coefficient of variation of 5.84. The prices are distributed with arithmetic mean of 1.28. The median price for the last 90 days is 1.25. The company had 4:3 stock split on 6th of September 2021.Open | High | Low | Close | Volume | ||
11/25/2024 | 1.24 | 1.25 | 1.23 | 1.25 | 205,600 | |
11/22/2024 | 1.24 | 1.25 | 1.24 | 1.24 | 1,038,300 | |
11/21/2024 | 1.26 | 1.26 | 1.24 | 1.25 | 290,900 | |
11/20/2024 | 1.25 | 1.27 | 1.25 | 1.26 | 259,600 | |
11/19/2024 | 1.23 | 1.27 | 1.23 | 1.25 | 410,800 | |
11/18/2024 | 1.22 | 1.23 | 1.21 | 1.23 | 366,100 | |
11/15/2024 | 1.22 | 1.23 | 1.22 | 1.22 | 165,700 | |
11/14/2024 | 1.23 | 1.23 | 1.22 | 1.23 | 1,876,300 | |
11/13/2024 | 1.22 | 1.23 | 1.22 | 1.23 | 182,700 | |
11/12/2024 | 1.23 | 1.25 | 1.22 | 1.23 | 2,532,400 | |
11/11/2024 | 1.25 | 1.25 | 1.22 | 1.23 | 4,201,000 | |
11/08/2024 | 1.26 | 1.26 | 1.24 | 1.25 | 466,100 | |
11/07/2024 | 1.26 | 1.27 | 1.23 | 1.25 | 2,388,400 | |
11/06/2024 | 1.28 | 1.28 | 1.24 | 1.24 | 4,803,900 | |
11/05/2024 | 1.28 | 1.29 | 1.27 | 1.28 | 286,900 | |
11/04/2024 | 1.27 | 1.28 | 1.26 | 1.28 | 235,000 | |
11/01/2024 | 1.27 | 1.28 | 1.26 | 1.27 | 446,700 | |
10/30/2024 | 1.28 | 1.29 | 1.26 | 1.26 | 966,500 | |
10/29/2024 | 1.30 | 1.31 | 1.29 | 1.29 | 423,200 | |
10/28/2024 | 1.32 | 1.33 | 1.30 | 1.31 | 495,500 | |
10/25/2024 | 1.31 | 1.33 | 1.31 | 1.33 | 286,300 | |
10/24/2024 | 1.32 | 1.35 | 1.30 | 1.31 | 588,200 | |
10/23/2024 | 1.37 | 1.37 | 1.33 | 1.33 | 1,066,300 | |
10/22/2024 | 1.37 | 1.38 | 1.37 | 1.38 | 394,900 | |
10/21/2024 | 1.38 | 1.39 | 1.36 | 1.37 | 3,405,700 | |
10/18/2024 | 1.38 | 1.39 | 1.37 | 1.38 | 565,500 | |
10/17/2024 | 1.39 | 1.41 | 1.38 | 1.39 | 1,110,300 | |
10/16/2024 | 1.39 | 1.40 | 1.37 | 1.39 | 534,400 | |
10/15/2024 | 1.37 | 1.40 | 1.37 | 1.39 | 1,052,700 | |
10/14/2024 | 1.37 | 1.39 | 1.37 | 1.38 | 376,800 | |
10/11/2024 | 1.38 | 1.38 | 1.36 | 1.37 | 284,400 | |
10/10/2024 | 1.36 | 1.38 | 1.36 | 1.38 | 256,000 | |
10/09/2024 | 1.35 | 1.37 | 1.35 | 1.37 | 704,200 | |
10/08/2024 | 1.38 | 1.38 | 1.34 | 1.35 | 806,400 | |
10/07/2024 | 1.38 | 1.42 | 1.37 | 1.39 | 1,575,000 | |
10/04/2024 | 1.38 | 1.38 | 1.35 | 1.38 | 632,600 | |
10/03/2024 | 1.36 | 1.39 | 1.34 | 1.37 | 1,107,300 | |
10/02/2024 | 1.36 | 1.37 | 1.35 | 1.37 | 905,800 | |
10/01/2024 | 1.37 | 1.39 | 1.37 | 1.37 | 814,000 | |
09/30/2024 | 1.36 | 1.37 | 1.32 | 1.36 | 4,411,800 | |
09/27/2024 | 1.40 | 1.40 | 1.35 | 1.37 | 2,358,600 | |
09/26/2024 | 1.40 | 1.45 | 1.39 | 1.40 | 7,299,300 | |
09/25/2024 | 1.34 | 1.40 | 1.33 | 1.39 | 4,520,800 | |
09/24/2024 | 1.24 | 1.32 | 1.23 | 1.31 | 2,933,400 | |
09/23/2024 | 1.24 | 1.25 | 1.23 | 1.24 | 123,200 | |
09/20/2024 | 1.24 | 1.25 | 1.21 | 1.23 | 752,700 | |
09/19/2024 | 1.24 | 1.26 | 1.24 | 1.24 | 440,900 | |
09/18/2024 | 1.20 | 1.25 | 1.20 | 1.24 | 1,536,600 | |
09/17/2024 | 1.18 | 1.20 | 1.18 | 1.20 | 213,600 | |
09/13/2024 | 1.17 | 1.18 | 1.17 | 1.17 | 67,300 | |
09/12/2024 | 1.17 | 1.18 | 1.17 | 1.17 | 159,200 | |
09/11/2024 | 1.20 | 1.20 | 1.16 | 1.16 | 953,600 | |
09/10/2024 | 1.19 | 1.20 | 1.17 | 1.19 | 621,500 | |
09/09/2024 | 1.17 | 1.19 | 1.17 | 1.19 | 414,000 | |
09/06/2024 | 1.18 | 1.19 | 1.17 | 1.18 | 124,600 | |
09/05/2024 | 1.18 | 1.19 | 1.16 | 1.18 | 709,900 | |
09/04/2024 | 1.19 | 1.20 | 1.16 | 1.18 | 699,000 | |
09/03/2024 | 1.22 | 1.23 | 1.19 | 1.20 | 1,395,700 | |
09/02/2024 | 1.23 | 1.24 | 1.22 | 1.22 | 845,500 | |
08/30/2024 | 1.22 | 1.22 | 1.21 | 1.21 | 205,200 | |
08/29/2024 | 1.21 | 1.23 | 1.19 | 1.21 | 842,600 |
About Duopharma Biotech Stock history
Duopharma Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Duopharma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Duopharma Biotech Bhd will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Duopharma Biotech stock prices may prove useful in developing a viable investing in Duopharma Biotech
Duopharma Biotech Stock Technical Analysis
Duopharma Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
All Next | Launch Module |
Duopharma Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Duopharma Biotech's price direction in advance. Along with the technical and fundamental analysis of Duopharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Duopharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.023 | |||
Jensen Alpha | 0.043 | |||
Total Risk Alpha | (0.23) | |||
Sortino Ratio | (0.05) | |||
Treynor Ratio | (0.22) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Duopharma Stock
Duopharma Biotech financial ratios help investors to determine whether Duopharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Duopharma with respect to the benefits of owning Duopharma Biotech security.